June 25th, 2019 | Lille
CoBra – Technical Workshop on Brachytherapy will be held during MedFit with an after-noon conference the 25th of June. CoBra will also hold a stand during MedFit convention and participate to MedFit one-to-one meetings.
>>> More information coming soon <<<
- Registration to CoBra – Technical Workshop on Brachytherapy is free but mandatory, it gives you a free access for the afternoon of the 25th of June to MedFIT.
- By participating to CoBra – Technical Workshop on Brachytherapy convention, you may obtain a 50% discount on your MedFIT pass for the second day, the 26th of June.
Technological innovation for biopsy and brachytherapy under MRI control, in order to improve diagnosis and treatment of localised cancers
Prostate cancer is the fourth most common cancer in Europe, for both combined sexes and the second most common cancer in men. Treatment of such cancer can be performed by surgery, external radiotherapy (RT) or brachytherapy. Surgery consists in removing the entire prostate, while RT involves irradiating the target volume with a particle accelerator. Brachytherapy is a technique better tolerated by patients, aiming to irradiate a target volume by placing radioisotopes emitting low or high ionizing radiation in it or in its contact, only in one intervention. However it presents also certain practical limits, such as: manual handling of radioactive needles that raises fears among practitioners; impotence, incontinence and trauma of patient.
The CoBra project aims to improve the quality of both diagnosis and treatment of localized cancers, by developing a new medical robot prototype for brachytherapy and biopsy under guidance of MRI. The overall objective of the project is to improve the accuracy of cancer diagnosis, and increase the accuracy of treatment, increasing cure rates and minimising side effects. The prostate and other soft tissues will be the main localized cancers of interest in the Cobra project.
More info : https://cobra-2seas.eu/